January 31, 2018 / 9:53 PM / in 7 months

BRIEF-Gemphire Announces Initiation Of Phase 2A Clinical Trial Of Pediatric NAFLD

Jan 31 (Reuters) - Gemphire Therapeutics Inc:

* GEMPHIRE ANNOUNCES INITIATION OF PHASE 2A CLINICAL TRIAL OF GEMCABENE IN PEDIATRIC NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD)

* GEMPHIRE THERAPEUTICS INC - ‍TOP LINE RESULTS FROM PEDIATRIC NAFLD TRIAL ARE EXPECTED IN EARLY 2019​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below